Dinutuximab-beta and Chemotherapy in Newly Diagnosed High-Risk Neuroblastoma

NCT07688252 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

High Risk Neuroblastoma

Interventions

BIOLOGICAL: Dinutuximab Beta
DRUG: Induction chemotherapy

Sponsor

Chang Gung Memorial Hospital

Collaborators

[object Object]